Comparison of onset for intubation between priming rocuronium and without priming in general anesthesia

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

TCTR

Registry ID

TCTR20180928002

Enrollment

Unknown

Registered

2018-09-28

Start date

2017-09-01

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Side effect during priming interval

Interventions

Use priming dose 0.03mg/kg rocuronium IV before 0.57mg/kg roccuronium IV 3 mins.,Use Saline IV before 0.6mg/kg roccuronium IV 3 mins.

Active Comparator Drug,Placebo Comparator Drug

Priming group,Control group

Eligibility

Sex/Gender

All

Age

18 Years to 60 Years

Inclusion criteria

Inclusion criteria: Age 18-60 years Elective surgery under general anesthesia

Exclusion criteria

Exclusion criteria: Neuromuscular disease Hepatic disease Renal disease Lung disease Patient have risk of aspiration Suspected difficult intubation Allergy to roccuronium Obesity Operation time < 30 mins

Design outcomes

Primary

Measure	Time frame
Onset time of intubation 8mins Stop watch	—

Secondary

Measure	Time frame
Side effect during priming interval 3 mins Ask Patient,TOF at 1 min 1 min Nerve stimulation,Intubation score 8mins Scoring system by Cooper	—

Countries

THAILAND

Contacts

Public ContactNUDTAPOD RUTANABUREE

SRINAKHARINWIROT UNIVERSITY

nurngnoi@gmail.com0858184868

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026